---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-033682"
form_type: "8-K"
ticker: null
cik: "0001850906"
company_name: "Singular Genomics Systems, Inc."
filed_at: "2023-07-20T23:59:59+00:00"
generated_at: "2026-06-13T05:48:35.382275+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Singular Genomics receives Nasdaq deficiency notice for bid price below $1.00

## Summary
- Received deficiency letter on July 17, 2023, for failure to meet $1.00 minimum bid price for 30 consecutive days.
- Has 180 calendar days, until January 15, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
- May qualify for additional 180-day period if it transfers to Nasdaq Capital Market and meets requirements.
- Stock continues trading under symbol OMIC; no immediate delisting effect.
- Company intends to monitor and consider options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0000950170-23-033682
- form_type: 8-K
- cik: 0001850906
- company_name: Singular Genomics Systems, Inc.
- filed_at: 2023-07-20T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850906/000095017023033682/0000950170-23-033682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850906/000095017023033682/omic-20230717.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-033682
- JSON: https://secwatch.observer/filing/0000950170-23-033682.json
- Plain text: https://secwatch.observer/filing/0000950170-23-033682.txt

## Key facts
- Listing & Compliance Notices
  Singular Genomics Systems, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5450(a)(1)
  source text: July 17, 2023, Singular Genomics Systems, Inc. (the “Company”) received a deficiency letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the preceding 30 consecutive business days prior to the date of the Letter, the bid price for the Company’s common stock (the “Common Stock”) closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Letter is a notice of deficiency, and not delisting, and has no imm
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850906/000095017023033682/0000950170-23-033682-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.